Foreign Company Eye Asia-Pacific IVF Devices & Consumables Market to Expand

In-vitro fertilization is associated with reproductive technology. It consists of a range process needed for treating various infertility issues. Besides this, it comprises of the fertilization of ovum which is followed by the implantation of embryo into a uterus. IVF technology is rapidly gaining momentum in the Asia –Pacific, as the number of infertility rates are on the rise.  Research analysts at Allied Market Research keeping a track of the major trends, growth rate and share and size in the Asia-Pacific IVF devices and consumables market say rise in the geriatric population is of key concern for several nations having below an average birth rate. These countries include Philippines, Vietnam, Indonesia and Cambodia among others. 

Companies eye Asia-Pacific IVF Devices and Consumables Market to Boost Earnings 

Today, several companies have turned their attention to Asia, to improve their earning profile. The outcome has been positive so far. Many of these companies have their base in Australia. A reputed company based in Australia, named Monash IVF has its focus on China, which is one of the biggest market, when it comes to IVF. Professional at the company say that Malaysia is second in the list and it will soon expand its operations in the country. This fertility brand has been behind the world’s topmost and first in vitro fertilization pregnancy forty three years back is finally making the most of China’s relaxation associated with the one –child policy. 

Asia-Pacific IVF Devices and Consumables Market Players Invest Generously 

International companies are planning on investing in Asia – Pacific generously to expand their fertility clinics in the region. Elaborating the numerous growth prospects in the IVF markets like India, China, Malaysia etc., founders of the companies are confident that their facilities can help over 25 million couples in these countries deal with fertility issues. In a recent news Medicover shot to fame for investing around USD 100 million to establish 50 clinics in India in the coming three years. Commenting on their recent measures John Stubbington the chief executive office at the division said "We are currently present in geographies like the UK, Poland, Ukraine and now plan to invest USD 100 million in India over the next three fiscals to set up 50 fertility clinics." Gaurav Malhotra, the managing director at the company said that after Delhi NCR Medicover is planning on expanding their business in many northern states such as Punjab as well as Haryana and further move to destinations in central part of India. 

Eyeing the major developments in the sector, Allied Market Research has published a report titled “Asia-Pacific IVF Devices and Consumables Market - Opportunities and Forecasts, 2014 – 2020.” Research analysts conducting the study weigh up on the key business imperatives such as share and size, major growth as well as trends shaping the future prospects of the company. The research covers various companies such as Cooper Surgical, Inc., Thermo Fisher Scientific, Inc., Irvine Scientific and Merck Serono, Inc. among others. Stakeholders assessing the market by instruments, technology, media, end-users and geography would find the report beneficial. 

Related Post